These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23042950)

  • 1. Macrophages modulate cardiac function in lipotoxic cardiomyopathy.
    Schilling JD; Machkovech HM; Kim AH; Schwendener R; Schaffer JE
    Am J Physiol Heart Circ Physiol; 2012 Dec; 303(11):H1366-73. PubMed ID: 23042950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mouse model of lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Ford DA; Hsu FF; Garcia R; Herrero P; Saffitz JE; Schaffer JE
    J Clin Invest; 2001 Apr; 107(7):813-22. PubMed ID: 11285300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathy.
    Khan RS; Chokshi A; Drosatos K; Jiang H; Yu S; Harris CR; Schulze PC; Homma S; Blaner WS; Shulman GI; Huang LS; Goldberg IJ
    J Cardiovasc Pharmacol; 2013 Apr; 61(4):345-54. PubMed ID: 23567901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice.
    Chen W; Chen W; Xia Y; Zhao X; Wang H; Yu M; Li Y; Ye H; Zhang Y
    Mol Biol Rep; 2013 Mar; 40(3):2449-59. PubMed ID: 23196711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
    Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
    Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
    Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Lapachone ameliorates lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.
    Jeong MH; Tran NK; Kwak TH; Park BK; Lee CS; Park TS; Lee YH; Park WJ; Yang DK
    PLoS One; 2014; 9(3):e91039. PubMed ID: 24614171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
    Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity.
    Liu L; Shi X; Bharadwaj KG; Ikeda S; Yamashita H; Yagyu H; Schaffer JE; Yu YH; Goldberg IJ
    J Biol Chem; 2009 Dec; 284(52):36312-36323. PubMed ID: 19778901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase deficiency attenuates lipotoxic cardiomyopathy via upregulation of AMPK-mTORC mediated autophagy.
    Wang L; Zhao D; Tang L; Li H; Liu Z; Gao J; Edin ML; Zhang H; Zhang K; Chen J; Zhu X; Wang D; Zeldin DC; Hammock BD; Wang J; Huang H
    J Mol Cell Cardiol; 2021 May; 154():80-91. PubMed ID: 33378686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.
    Lee Y; Naseem RH; Duplomb L; Park BH; Garry DJ; Richardson JA; Schaffer JE; Unger RH
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13624-9. PubMed ID: 15347805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.
    Chen W; Lai Y; Wang L; Xia Y; Chen W; Zhao X; Yu M; Li Y; Zhang Y; Ye H
    J Diabetes Complications; 2015 Mar; 29(2):164-75. PubMed ID: 25499591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A murine model of isolated cardiac steatosis leads to cardiomyopathy.
    Glenn DJ; Wang F; Nishimoto M; Cruz MC; Uchida Y; Holleran WM; Zhang Y; Yeghiazarians Y; Gardner DG
    Hypertension; 2011 Feb; 57(2):216-22. PubMed ID: 21220706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacylglycerol acyl transferase 1 overexpression detoxifies cardiac lipids in PPARγ transgenic mice.
    Liu L; Yu S; Khan RS; Homma S; Schulze PC; Blaner WS; Yin Y; Goldberg IJ
    J Lipid Res; 2012 Aug; 53(8):1482-92. PubMed ID: 22628613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.
    Fatkin D; Christe ME; Aristizabal O; McConnell BK; Srinivasan S; Schoen FJ; Seidman CE; Turnbull DH; Seidman JG
    J Clin Invest; 1999 Jan; 103(1):147-53. PubMed ID: 9884344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Endogeneous Peptide Mitigates Myocardial Remodeling in a Mouse Model of Cardioselective Galectin-3 Overexpression.
    Sonkawade SD; Pokharel S; Karthikeyan B; Kim M; Xu S; Kc K; Sexton S; Catalfamo K; Spernyak JA; Sharma UC
    Circ Heart Fail; 2021 Sep; 14(9):e008510. PubMed ID: 34415177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor.
    Zhang X; Azhar G; Chai J; Sheridan P; Nagano K; Brown T; Yang J; Khrapko K; Borras AM; Lawitts J; Misra RP; Wei JY
    Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1782-92. PubMed ID: 11247792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat.
    Cernecka H; Doka G; Srankova J; Pivackova L; Malikova E; Galkova K; Kyselovic J; Krenek P; Klimas J
    Eur J Pharmacol; 2016 Nov; 791():244-253. PubMed ID: 27592051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.